1 |
Lu L, Wang S, Shen H, Zhang F, Ma F, Shi Y, Ning Y. Case Report: A case of COL1A1–PDGFB fusion uterine sarcoma at cervix and insights into the clinical management of rare uterine sarcoma. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1108586] [Reference Citation Analysis]
|
2 |
Xu B, Suurmeijer AJH, Agaram NP, Antonescu CR. Head and Neck Mesenchymal Tumors with Kinase Fusions: A Report of 15 Cases With Emphasis on Wide Anatomic Distribution and Diverse Histologic Appearance. Am J Surg Pathol 2023;47:248-58. [PMID: 36638315 DOI: 10.1097/PAS.0000000000001982] [Reference Citation Analysis]
|
3 |
Wang X, Liu X, Guo S. Perioperative Suppression of Schwann Cell Dedifferentiation Reduces the Risk of Adenomyosis Resulting from Endometrial–Myometrial Interface Disruption in Mice. Biomedicines 2022;10:1218. [DOI: 10.3390/biomedicines10061218] [Reference Citation Analysis]
|
4 |
Dang X, Xiang T, Zhao C, Tang H, Cui P. EML4-NTRK3 Fusion Cervical Sarcoma: A Case Report and Literature Review. Front Med (Lausanne) 2022;9:832376. [PMID: 35572973 DOI: 10.3389/fmed.2022.832376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Croce S, Perret R, Le Loarer F. Update on Mesenchymal Lesions of the Lower Female Genital Tract. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.02.009] [Reference Citation Analysis]
|
6 |
Niu S, Zheng W. Endometrial stromal tumors: Diagnostic updates and challenges. Seminars in Diagnostic Pathology 2022. [DOI: 10.1053/j.semdp.2022.01.004] [Reference Citation Analysis]
|